Close Menu
    What's Hot

    Delcam Retirement Benefits Scheme Completes Bulk Purchase Annuity Transaction With Royal London

    November 5, 2026

    JAB Insurance completes acquisition of Utmost Life and Pensions

    October 29, 2026
    Milliman

    Competitive US Pension Risk Transfer Cost Decreases During September

    October 28, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Symetra and TIAA Partner To Launch Mariner Re

      October 27, 2026

      Chariot Re Announces Fourth Reinsurance Transaction, First Covering Japanese Liabilities

      October 15, 2026

      Pacific Life Re Executes First Asset-Intensive Reinsurance Transaction in Hong Kong

      September 9, 2026

      Bermuda Life & Annuity Sidecar Market Quadruples as Alternative Asset Manager/Life Insurance Convergence Continues

      September 9, 2026

      Q&A: Alexandr Dudarev, CEO, Inshurik

      October 28, 2026

      Is Dementia the Next Big Longevity Event?

      October 15, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Delcam Retirement Benefits Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      November 5, 2026

      JAB Insurance completes acquisition of Utmost Life and Pensions

      October 29, 2026
      Milliman

      Competitive US Pension Risk Transfer Cost Decreases During September

      October 28, 2026

      New Report Highlights Tighter Regulatory Oversight of Asset-Intensive Reinsurance

      October 28, 2026

      Record Low Mortality Rates So Far in 2026 in England and Wales, Says CMI

      October 12, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      UK Equity Release Activity Nudges Higher in Third Quarter

      October 28, 2026

      Household Capital Completes New Reverse Mortgage Securitisation

      October 22, 2026

      New Report Suggests Life Settlement Market Poised for Long-Term Expansion

      October 15, 2026

      Further Declines in HECM Endorsements Suggest Urgent Reform is Needed

      October 15, 2026

      Delcam Retirement Benefits Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      November 5, 2026

      JAB Insurance completes acquisition of Utmost Life and Pensions

      October 29, 2026
      Milliman

      Competitive US Pension Risk Transfer Cost Decreases During September

      October 28, 2026

      UK Equity Release Activity Nudges Higher in Third Quarter

      October 28, 2026
    • Events
    • Latest Issues
      Life Risk News Editors Letter

      Editor’s Letter – Volume 2, Issue 10, October 2026

      October 15, 2026

      Editor’s Letter – Volume 2, Issue 9, September 2026

      September 9, 2026

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Litigation Update: U.S. Bank National Association v. Pacific Life Insurance Company

    Secondary Life Markets September 23, 2026By Greg Winterton
    Litigation
    Share
    Twitter LinkedIn Email

    On 11th August 2026, Judge Thomas J. Lo of the Superior Court of California, Orange County ruled in U.S. Bank National Association v. Pacific Life Insurance Company (Case No. 30-2023-01330408-CU-IC-CJC), denying Pacific Life Insurance Company’s motion for summary judgment and also denying U.S. Bank National Association’s cross-motion for summary judgment. The court held that a $20m life insurance policy procured using nonrecourse premium financing was not automatically void ab initio under Delaware’s insurable interest statute.  

    The legal dispute centred on whether the policy lacked a lawful insurable interest at the time it was issued. U.S. Bank National Association acted as the plaintiff in its capacity as securities intermediary for the policy’s entitlement holder, FCI III (an affiliate of Apollo), while Pacific Life Insurance Company served as the issuing insurer. 

    The policy in question insured the life of Judith Weiser, a Florida resident, for a $20m death benefit. It was procured through a Delaware statutory trust using a 30-month nonrecourse loan, a financing arrangement in which the lender’s sole recourse upon default was the policy itself, rather than the borrower’s personal assets.  

    Approximately one week before the loan matured, the policy was relinquished to Coventry, which provided the original financing, in satisfaction of the debt. The policy was acquired by FCI III in late 2017, with U.S. Bank acting as securities intermediary. Following Weiser’s death, U.S. Bank sought to collect the death benefit. Pacific Life refused payment, contending the policy was void for lack of insurable interest because the premiums were funded by nonrecourse financing.  

    Both parties moved for summary judgment in the Superior Court of California, Orange County. Pacific Life argued that, under Delaware law, a policy funded entirely by nonrecourse financing lacks an insurable interest and is void. U.S. Bank countered that Weiser procured the policy to address financial liquidity issues in her estate plan, which is a lawful insurance purpose recognised by Delaware’s courts. 

    The court determined that Delaware law governed the insurable interest question. 

    Applying the framework from Lavastone Capital LLC v. Estate of Berland, 266 A.3d 964 (Del. 2021) (Berland), a leading Delaware Supreme Court decision on insurable interest, the court held that the analysis involves two considerations: (1) whether the insured obtained the policy in good faith for a lawful insurance purpose, and not as a cover for a wager; and (2) the source of funding for the premiums. While nonrecourse financing can serve as evidence that insurable interest is not present at the time a policy is taken out, the court observed that Berland expressly states that premium financing “is a recognized and permissible tool” if used for a legitimate insurance purpose such as estate planning. 

    The court rejected Pacific Life’s argument that Estate of Barotz v. Vida Longevity Fund, L.P., 2022 WL 16833545 (Del. Super. Ct. 2022), aff’d, 320 A.3d 212 (Del. 2024) (Barotz), stood for the proposition that a court need not address lawful insurance purpose to find a nonrecourse-funded policy void. Finding that U.S. Bank presented admissible evidence of Weiser’s estate planning purpose, the court determined that disputed issues of fact remained.  

    The court denied both Pacific Life’s motion and U.S. Bank’s cross-motion for summary judgment, holding that the question of whether the policy is void requires a trial on the disputed facts. 

    2026 - September Life Settlement Litigation Volume 2 Issue 10 – October 2026
    Share. Twitter LinkedIn Email

    Related Posts

    Life Risk News Editors Letter

    Editor’s Letter – Volume 2, Issue 10, October 2026

    October 15, 2026By Chris Wells

    New Report Suggests Life Settlement Market Poised for Long-Term Expansion

    October 15, 2026By Greg Winterton

    Is Dementia the Next Big Longevity Event?

    October 15, 2026By Richard Marshall and Scott Hamilton

    Further Declines in HECM Endorsements Suggest Urgent Reform is Needed

    October 15, 2026By Greg Winterton
    Latest Issue

    New Report Suggests Life Settlement Market Poised for Long-Term Expansion

    October 15, 2026

    Is Dementia the Next Big Longevity Event?

    October 15, 2026

    Further Declines in HECM Endorsements Suggest Urgent Reform is Needed

    October 15, 2026

    The Structural Decision for Setting Up a Life Settlement Vehicle in Ireland

    September 23, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.